Clinical Trial Update: The Benefits of Intracytoplasmic Morphologically Selected Sperm Injection (IMSI) in Couples With Unexplained Infertility [NA]

View source ↗

Summary

The clinical trial NCT01729533 evaluating intracytoplasmic morphologically selected sperm injection (IMSI) for unexplained infertility has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility
• Unexplained Infertility

Snippet

Sponsor: Sapientiae Institute | Conditions: Pregnancy | NA | Status: WITHDRAWN